Intercure annual return on equity
2020
2021
2022
2023
2024
2025
Intercure Return on Equity (ROE) Growth & History (INCR)
Intercure's return on equity was −9.00% for fiscal 2025.
View full Intercure company overviewIntercure annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −9.00% | +8.09 pp |
| 2024 | 2024-12-31 | −17.09% | −3.80 pp |
| 2023 | 2023-12-31 | −13.29% | −22.50 pp |
| 2022 | 2022-12-31 | 9.22% | +7.20 pp |
| 2021 | 2021-12-31 | 2.02% | +15.60 pp |
| 2020 | 2020-12-31 | −13.58% | — |
Intercure return on equity trends
Over the last five fiscal years, Intercure's return on equity increased from −13.58% to −9.00%, a change of +4.58 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intercure source filings ↗Community posts
InterCure resolves Nasdaq minimum-bid-price deficiency
InterCure ($INCR) received written confirmation that it has regained compliance with Nasdaq’s minimum-bid-price requirement. Its shares had closed at or above $1 for ten consecutive business days, allowing Nasdaq to close the specific defic ...